TPG Biotech

TPG Biotech is a specialized investment platform operating under the umbrella of TPG Capital, a leading global alternative asset firm. Based in San Francisco, it is dedicated to providing growth-stage equity and venture capital to companies within the dynamic biotechnology industry. This platform leverages TPG's extensive resources and deep expertise in healthcare to identify and support innovative companies poised for significant impact and commercialization.

The platform's investment strategy is focused on companies developing novel therapeutics, diagnostics, and medical devices that address unmet medical needs. TPG Biotech typically engages with companies that are beyond the very early stages, often providing capital for critical phases such as clinical development, regulatory approval, and market commercialization. Their involvement often extends to strategic guidance, operational support, and leveraging TPG's vast network to accelerate portfolio company growth.

As part of TPG Capital's robust healthcare investment practice, TPG Biotech benefits from a long history of significant capital deployment in the sector. TPG Capital has collectively invested over $20 billion across more than 70 healthcare companies globally, demonstrating a profound commitment to the industry. For TPG Biotech's specific investments, typical first check sizes can range from approximately $25 million for later-stage venture opportunities to upwards of $200 million for substantial growth equity rounds, reflecting their capacity to lead or co-lead significant financings. This broad range allows them to support a diverse set of companies requiring substantial capital to scale.